Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Inguinal Hernia Repair

NCT00146198 is registered in ClinicalTrials.gov with AlgoRx Pharmaceuticals as lead sponsor.

NCT NCT00146198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Inguinal Hernia Repair
Lead sponsor
AlgoRx Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
February 28, 2006
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain